Key View

• We have made an upward revision to our forecasts of the Chinese residential buildings sector, as we now expect a short-term pickup in growth with the government seeking to boost economic growth via investments in real estate so as to cushion the impact of the ongoing US-China trade disputes on the economy.
• In the longer term, we expect

Key View:

• China remains the clear global leader for 5G, with strong state support and substantial scale being key tailwinds for the new technology.
• Blacklisting of Huawei will have little short-term impact to domestic 5G plans, although prolonged trade tensions will have strong negative effects.

Reportedly, the Ministry of Industry and

Key View

• India continues to present a highly dynamic pharmaceutical trade environment and the country is well positioned to exploit the highly import-dependent developed markets such as the US and the UK. 
• However, increased competitive intensity, substandard quality of medicines and pricing control will create a challenging operating landscape

Key View

• China’s far-reaching healthcare reforms will be a positive for the sector.
• The pharmaceutical sector is well-placed to see an uptick in foreign drugmaker activity. 
• Emerging market growth potential will offset challenges for drugmakers.

China will continue to benefit from significant investment from the innovative pharmaceutical

Key View:

• The announcement of a USD1.8bn investment by State Grid Corporation of China in Ethiopia’s electricity transmission networks represents an important step towards the country becoming a regional hub for power generation.
• The investment will improve the efficient distribution of generated electricity produced across Ethiopia’s broader

Key View:

• Luckin Coffee disclosed the number of shares it expects to sell and the amount it is seeking to raise in its Initial Public Offering (IPO), first announced April 22 2019, as the company progresses with its rapid expansion plans.
• Starbuck's is Luckin Coffee's main rival in China as both vie for a greater stake in the country's booming

Key View:

• Luckin Coffee disclosed the number of shares it expects to sell and the amount it is seeking to raise in its Initial Public Offering (IPO), first announced April 22 2019, as the company progresses with its rapid expansion plans.
• Starbuck's is Luckin Coffee's main rival in China as both vie for a greater stake in the country's booming

Key View

• The Chinese pharmaceutical market continues to hold significant potential as the largest in Asia Pacific.
• The demand for innovative cancer treatments in China will be driven by the increasing burden of chronic diseases. 
• New regulatory pathways and improvements to China’s drug approval process will bolster long-term growth

Key View

• We at Fitch Solutions believe that the Belt and Road Initiative is approaching a critical mass of participating countries and that the participation of key European countries will tip the scales.
• In order to address concerns, especially around financing, of participating and interested countries, we expect Beijing to increase its